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Introduction: Hypertension (HTN) control is a major public health and clinical challenge. A number of guidelines
exist globally to assist in tackling this challenge. The aim of this study was to determine conformity of the HTN
detection and evaluation practices of a sample of Lagos-based general practitioners (GPs) to international guidelines.
Methods: Self-administered structured questionnaires were used to collect data from a cohort of GPs attending
continuing medical education programs in Lagos.
Results: Out of the 460 GPs that were approached, 435 agreed to participate in the study, with questionnaires from 403
GPs analyzed. The average age and number of years post-registration of the GPs were 40.0 ± 11.3 years and 14.3 ± 11.1
years, respectively. Two thirds (n = 269) were in private practice. Their daily average total and HTN patients’ loads were
17.4 ± 14.3 and 4.4 ± 3.5, respectively. Awareness of HTN guidelines was 46.7% (n= 188), while 18.1% (n = 73) was able
to name one or more HTN guidelines. The approaches of these GPs to the detection and evaluation of HTN and their
relationships to the GPs’ experience were heterogeneous.
Discussion: The approach of the GPs to detection and evaluation of HTN though heterogeneous is unsatisfactory
and may partly contribute to poor HTN control in Nigeria. Strengthening the capacity of GPs in this regard through
continuous medical education may greatly improve HTN control.
Keywords: Hypertension, Detection, Evaluation, General medical practitioners, Hypertension guidelinesIntroduction
Hypertension (HTN) is the leading cardiovascular (CV)
risk factor for morbidity and mortality worldwide [1]. It
is also the most common condition in primary care [2].
Two thirds of an estimated 26.4% of the global adult
population having HTN live in developing countries,
with West Africa having HTN prevalence of 19.3%–
54.6% [3,4].
Undetected, belatedly detected, untreated, or inappro-
priately treated HTN is associated with increased risk of
CV morbidity and mortality, while good HTN manage-
ment is associated with good CV prognosis [2,5,6]. Nu-
merous data from HTN studies and clinical trials have
provided newfound capabilities for lowering blood pres-
sure (BP) in almost every person with HTN [6]. These
data collated globally have been summarized into HTN
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and Prevention in Africa (IFHA) recommendations for
prevention, diagnosis, and management of HTN and CV
risk factors in sub-Saharan Africa (SSA) is one of the nu-
merous HTN guidelines available globally [7]. The IFHA
guidelines follow the main lines stated in the 2003
WHO/ISH Statement on Management of HTN [8], the
2002 WHO CV Risk Management Package in Low- and
Medium-Resource Settings [9], the American JNC 7
guidelines [10], the European guidelines [11], a consen-
sus statement of the HTN in African-American working
group of the International Society on HTN in Blacks
[12], and European Society of HTN recommendations
for blood pressure measurement [7,13].
Despite the above, HTN still remains a major public
health concern with increasing prevalence and poor con-
trol worldwide [4,6,8,14,15]. HTN studies in Nigeria and
Ghana showed 14%–73% awareness, 3%–86% on treat-
ment, and 2%–13% with controlled BP [4]. This global
problem of poor HTN control is partly due to a failuree distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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[15]. Therefore, the implementation of appropriate
mechanisms required for the detection of HTN which are
included in guidelines should positively impact hyperten-
sion control [7,8,10-12].
HTN often coexists with other CV risk factors, such as
diabetes, dyslipidemia, tobacco use, and obesity, which are
often inadequately addressed [8]. Hence, guidelines recom-
mend total CV risk assessment of patients because it allows
for a better adaptation of a patient’s clinical management
[7,8,10]. CV risk assessment is done through medical
history, physical examination, laboratory tests, and other
diagnostic procedures.
A very high prevalence of target organ damage in
Nigerians newly diagnosed with HTN suggests delayed
detection of HTN [16]. This makes proper evaluation of
newly diagnosed hypertensive persons imperative as rec-
ommended by HTN guidelines [7,8,10-12,17]. HTN has
been reported to be poorly diagnosed in general medical
practice [11]. Physician surveys and practice audits have
revealed that the approach to the diagnosis, investiga-
tion, and treatment of HTN differs among geographical
areas and over time [18]. The approach of primary care
physicians may among other reasons such as the asymp-
tomatic nature of HTN be partly responsible for poor
detection and control of HTN. This study sought to de-
termine the approach of general medical practitioners
(GPs) in Lagos, the commercial capital and former ad-
ministrative capital of Nigeria to the detection and
evaluation of high BP and its agreement with the IFHA
guidelines. We also determined the relationships of the
GPs’ experience to their approach.
Methods
The study was an exploratory survey of Lagos-based
GPs attending continuing medical education program in
Lagos, Nigeria. All the attending GPs who met the
criteria for the study were approached. Inclusion criter-
ion was full registration with the Medical and Dental
Council of Nigeria. Physicians with specialty training in
internal medicine or any of its subspecialties were
excluded.
Ethical clearance was obtained from the Ethics and Re-
search Committee of the Lagos University Teaching
Hospital. The study was conducted to conform to the
ethical tenets developed by the World Medical Associ-
ation, as espoused in the Declaration of Helsinki. Per-
mission to conduct the survey was obtained from the
program organizers. Verbal consent of each participant
was obtained.
Survey instrument
Anonymous self-administered questionnaire developed
in English consisting of open- and closed-ended questionswas used. The closed-ended questions had either yes/no or
Likert-type scale responses.
The study questionnaire had three basic themes as fol-
lows: (1) type of practice—private versus government
and number of patients seen, (2) detection of HTN—fre-
quency of BP checks in patients, rest before BP measure-
ment, number of BP readings, and BP threshold levels;
and (3) evaluation: (3a) clinical (personal history of dia-
betes mellitus, alcohol and tobacco habits, family history
of diabetes and HTN, evaluation for obesity, and BP
measurement in both arms on first visit) and (3b)
laboratory/ancillary (urinalysis, serum electrolytes and
creatinine, blood glucose, lipogram, electrocardio-
gram, and fundoscopy) evaluation of newly diagnosed
hypertensive patients. A yes or no question on aware-
ness of HTN guidelines was included, and physicians




Definitions were adopted for binary outcomes based on
the IFHA recommendations for prevention diagnosis
and management of HTN and cardiovascular risk factors
in sub-Saharan Africa [7].
Likert-type scale responses were transformed into di-
chotomous responses of appropriate/yes (“always done”
and “often or usually done”) and inappropriate/no
(“sometimes done,” “occasionally done,” “rarely or never
done”) practice.
Another Likert-like scale (strongly agree, agree, neu-
tral/undecided, disagree, and strongly disagree) response
to the statement “uncomplicated hypertension is usually
asymptomatic” was transformed into yes (strongly agree,
agree) and no (neutral/undecided, disagree, and strongly
disagree).
Statistics
The data were analyzed using Statistical Package for the
Social Sciences (SPSS, version 17.0). Descriptive statistics
were used to report the findings. Categorical and con-
tinuous variables were expressed as proportions and
means ± SD, respectively. Student t-test or Pearson chi-
square test was used when appropriate. All tests were
two-sided, and values were considered statistically sig-
nificant if p < 0.05. Cross tables were done between dem-
ography of respondents and questions.
Results
Out of the 460 physicians that were contacted, 435
agreed to participate with 403 of the questionnaires
found suitable for analysis. The demographic character-
istics of the respondents by experience (number of years
post-registration) are shown in Table 1. The mean age
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years and 14.3 ± 11.1 years, respectively. Most of the GPs
were males (61.8%, n = 249), in private practice (66.7%, n =
269) and unaware of HTN guidelines (53.3%, n = 215).
Table 2 shows the approach of the GPs to the detec-
tion of HTN. A quarter (25.3%, n = 102) of the GPs used
incorrect BP threshold for the diagnosis of HTN. Eighty
eight (86.3%) and 14 (13.7%) of these GPs gave threshold
values higher and lower respectively than the correct BP
threshold of ≥140/90 mmHg. Apart from threshold for
HTN diagnosis and routine BP check, there were no sig-
nificant differences in the approaches of the older and
recent medical graduates to the detection of HTN.
Table 3 shows the responses of the GPs to the ques-
tions on the evaluation of HTN. Apart from evaluation
for obesity (45.8%, n = 183) and dyslipidemia (41.2%, n =
166), majority of the GPs routinely carried out clinical
and laboratory evaluation on their newly diagnosed
hypertensive patients. The recently qualified GPs were
better than the older ones in terms of personal history
of diabetes, history of alcohol intake, and serum electro-
lytes and creatinine assay (p < 0.05). The converse is the
case urinalysis and physical activity evaluation (p < 0.05).
Table 4 shows the relationships of the total number of
patients seen per day, the number of hypertensive pa-
tients seen per day and the number of years post-
registration of respondents to selected knowledge and
practices of the physicians.
Discussion
Hypertension is largely asymptomatic in nature and can
only be diagnosed by measuring the BP. This informedTable 1 Demography of the respondents according to the nu
Variable (n) All
n (%)/mean ± SD
Number of physicians 403 (100%)




Years post-registration (403) 14.30 ± 11.10
Type of practice (403)
Private 269 (66.7%)
Government 134 (33.3%)
Number of patients seen per day (403) 17.39 ± 14.25
Number of HTN patients seen per day (396) 4.38 ± 3.50
Aware of guidelines (403) 188 (46.7%)
Able to name guidelines (403) 73 (18.1%)
HTN hypertension.IFHA guideline recommendation that health-care pro-
fessionals should measure the BP at every encounter
with health-care seekers [7]. A large proportion (30.4%)
of the respondents in this study did not routinely check
the BP of their adult patients in consultation, with this
practice commoner among the younger graduates. This
is less than 52.4% reported by Olubodun in a study of 42
Nigerian GPs [19]. A practice audit of 400 Italian GPs by
Filippi et al. showed that 27.8% of the patients seen over
a period of 1 year had no recorded BP values [20]. Nou-
biap et al. in study of 77 GPs based in Cameroon re-
ported that 80.5% of them routinely check the BP of
their adult patients in consultation [21]. Data on 2,618
consecutive adult patients presenting to 99 Australian
GPs over a 5-week period showed that BP had not been
recorded for 13% of the patients [22]. However; a survey
of 100 GPs in Lagos by Ajuluchukwu et al. reported that
all the respondents measured the BP of their adult cli-
ents most of the time [23]. In addition to differences in
methodology and varying abilities of GPs to recall, the
wide variability observed globally in the proportions of
GPs routinely checking the BP of adults in consultation
may be due to differences in patient load and the per-
ceptions of these GPs on the enormity of the public
health challenge posed by HTN.
A disproportionately higher number of the more expe-
rienced physicians were in private practice when com-
pared with the less experienced ones in our study. A
more meticulous approach to patient care coupled with
lighter patient load in private practice when compared
with government practice may explain the better prac-
tice in terms of routine BP checks observed among thember of years post registration
Years post-registration
<10 years ≥10 yrs χ2/p value
n (%)/mean ± SD n (%)/mean ± SD
189 (48.9%) 214 (53.1%) 3.10/0.078
30.28 ± 2.64 48.45 ± 8.96 <0.001
95 (51.6%) 154 (72%) 20.01/<0.001
94 (48.4%) 60 (28%)
4.12 ± 1.69 23.29 ± 7.55 <0.001
99 (52.3%) 170(79.4%) 33.11/<0.001
90 (47.7%) 44 (20.6%)
17.24 ± 16.42 18.46 ± 12.04 0.39
5.30 ± 3.90 3.57 ± 2. 37 <0.001
88 (46.6%) 100 (46.7%) 0.001/0.97
53 (28%) 20 (9.3%) 23.65/<0.001
Table 2 Detection of hypertension by the respondents according to the number of years post registration
Variable (n) All Years post-registration
n (%) <10 years ≥10 years χ2/p value
n (%) n (%)
Correct BP threshold for HTN diagnosis (403) 301 (74.7%) 151 (79.9%) 150 (70%) 5.10/0.024
Routinely check BP in practice (392) 273 (69.6%) 87 (48.9%) 186 (86.9%) 66.51/<0.001
Allow short rest before measuring BP (390) 103 (26.4%) 45 (24.8%) 58 (27.8%) 0.42/0.52
Take ≥2 BP readings before diagnosing HTN (403) 398 (98.8%) 189 (100%) 209 (97.7%) 4.47/0.034
Measure BP in both arms during first visit (390) 63 (16.2%) 23 (12.8%) 40 (18.6%) 2.67/0.10
Agree that uncomplicated HTN is asymptomatic (403) 281 (69.7%) 124 (65.6%) 157 (73.4%) 2.86/0.09
BP blood pressure, HTN hypertension.
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checking BP may account for the high prevalence of
undetected HBP and a consequent high prevalence of
target organ damage reported in newly diagnosed hyper-
tensive subjects in Nigeria [4,16].
The BP threshold for the diagnosis of hypertension is
the BP at which the benefits of drug treatment have
been definitely established in randomized placebo con-
trolled trials. This threshold has been a moving target
which had witnessed reductions over the past years as
more data on HTN streamed in. The majority (74.7%) of
the respondents used correct BP threshold for diagnos-
ing HTN. This proportion is higher than the 63.6% and
69.4% reported for Cameroon- and Pakistan-based GPs,
respectively [21,24]. A large majority (86%) of the GPs
using incorrect BP threshold values used values higher
than the correct BP threshold with this being commoner
among the more experienced GPs. This not only implies
under diagnosis of HTN but also suggests that the moreTable 3 Clinical and laboratory evaluation by the respondent
Evaluation (n) All Y
n (%) <
n
FH of HTN (398) 349 (87.7%) 1
FH of DM (403) 305 (75.7%) 1
PH of DM (400) 312 (78%) 1
Obesity evaluation (400) 183 (45.8%) 8
Alcohol history (403) 297 (73.7%) 1
Tobacco history (398) 297 (74.6%) 1
Physical activity (383) 251 (65.5%) 1
Urinalysis (403) 324 (80.4%) 1
Blood glucose (398) 248 (62.3%) 1
E U Cr (399) 245 (61.4%) 1
Lipogram (403) 166 (41.2%) 8
Fundoscopy (400) 21 (5.25%) 1
Electrocardiography (398) 204 (51.3%) 1
FH family history, HTN hypertension, PH personal history, DM diabetes mellitus, E Uexperienced GPs may be less familiar with the recent
hypertension guidelines having lower BP threshold for
the diagnosis of HTN.
Overweight/obesity is not just a highly prevalent con-
dition in West Africa with a prevalence of 4%–49% in
Nigeria; its prevalence is trending upwards in the region
[4,25]. HTN prevalence across various populations in-
crease with average body mass index, and it is known
that 75% of the incidence of HTN is related directly to
obesity [26,27]. Less than half of the respondents in the
current study routinely evaluated their newly diagnosed
hypertensive clients for obesity, thereby undermining
the effect of obesity on hypertension especially among
the Black. Indeed, obesity has been found to be the most
important cause of uncontrolled BP in certain popula-
tions and is also associated with increased morbidity and
mortality [28].
Lipogram was routinely carried out by 41.2% of the
GPs in the current study. This is in contrast to highers according to the number of years post-registration
ears post-registration
10 years ≥10 years χ2/p value
(%) n (%)
55 (84.2%) 194 (90.7%) 3.77/0.052
37 (72.5%) 168 (78.5%) 1.98/0.16
58 (84.9%) 154 (72%) 9.78/0.002
3 (43.9%) 100 (47.4%) 0.49/0.49
48 (78.3%) 149 (69.6%) 3.901/0.048
33 (70.4%) 164 (78.5%) 3.44/0.064
09 (59.2%) 142 (71.4%) 6.22/0.013
29 (68.3%) 196 (91.6%) 33.3/<0.001
17 (61.9%) 131 (62.7%) 0.028/0.87
31 (69.3%) 114 (54.3%) 9.48/0.002
2 (43.4%) 84 (43.4%) 0.71/0.40
0 (5.3%) 11 (5.2%) 0.001/0.97
05 (55.6%) 99 (47.4%) 2.67/0.103
Cr serum electrolytes and creatinine.
Table 4 Relationships of the number of patients seen per day, age and experience of physicians to selected practices


















Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Routinely check BP Y 17.7 ± 11.8 0.33 4.2 ± 3.2 0.34 43.8 ± 11. 5 <0.01 17.8 ± 11.2 <0.01
N 19.2 ± 19.9 4.6 ± 3.9 32.1 ± 5.5 7.1 ± 6.3
Correct HTN threshold Y 13.2 ± 14.5 0.53 3.8 ± 0.9 0.05 38.9 ± 10.6 <0.01 13.4 ± 10.8 <0.01
N 17.1 ± 13.5 4.6 ± 3.7 43.3 ± 12.7 17.0 ± 11.7
PH of diabetes Y 13.2 ± 15.4 0.58 4.6 ± 3.8 0.02 39.5 ± 10.6 0.03 13.4 ± 10.8 <0.01
N 17.2 ± 9.1 3.6 ± 2.2 42.6 ± 13.3 17.9 ± 11.5
FH of diabetes Y 16.5 ± 10.9 <0.01 4.4 ± 3.8 0.81 40.3 ± 10.6 0.57 14.7 ± 10.7 0.24
N 22.1 ± 1.1 4.3 ± 0.5 39.5 ± 13.5 13.2 ± 12.3
FH of HTN Y 16.4 ± 10.5 <0.01 4.4 ± 3.6 0.76 40.5 ± 10.8 0.25 14.8 ± 10.8 0.11
N 28.3 ± 27.7 4.2 ± 2.7 38.4 ± 15.0 12.0 ± 13.0
Obesity assessment Y 16.6 ± 0.8 0.11 4.2 ± 3.8 0.47 40.5 ± 10.4 0.57 14.2 ± 10.8 0.86
N 13.9 ± 16.7 4.5 ± 3.8 39.8 ± 12.2 14.4 ± 10.5
BG assessment Y 18.0 ± 11.7 0.80 4.6 ± 3.8 0.02 40.1 ± 11.6 0.61 15.6 ± 11.1 <0.01
N 17.6 ± 17.9 3.8 ± 2.9 39.5 ± 10.4 8.9 ± 9.5
Urinalysis Y 16.8 ± 11.3 <0.01 4.0 ± 3.5 <0.01 41.3 ± 11.5 <0.01 14.1 ± 11.2 0.84
N 22.2 ± 22.3 6.0 ± 2.9 35.1 ± 9.2 14.3 ± 10.9
E U Cr Y 17.6 ± 11.3 0.47 4.6 ± 3.8 0.14 39.1 ± 11.2 0.047 13.0 ± 10.9 <0.01
N 18.6 ± 18.1 4.1 ± 2.9 41.4 ± 11.4 16.0 ± 11.0
ECG Y 18.2 ± 12.1 0.72 4.7 ± 3.7 0.14 38.9 ± 10.3 0.15 12.9 ± 10.3 0.04
N 17.7 ± 16.4 4.1 ± 3.3 40.5 ± 11.3 15.2 ± 11.3
Lipogram Y 18.0 ± 12.9 0.93 5.1 ± 4.0 <0.01 39.6 ± 10.6 0.52 13.6 ± 11.2 0.4
N 17.8 ± 15.2 3.9 ± .07 40.4 ± 11.9 14.7 ± 11.1
HTN hypertension, FH family history, PH personal history, DM diabetes mellitus, BG blood glucose, E U Cr serum electrolytes and creatinine. ECG electrocardiography,
Y yes, N no.
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(50.7%) GPs [21,29]. This may be due to the suggestion
by the IFHA guidelines that lipid studies may be unimport-
ant in the evaluation of newly diagnosed hypertensive
Blacks of SSA [7]. This was premised on suggestions by the
older publications that serum lipid levels in Blacks of
SSA are low [30]. This practice is rather worrisome as
current data show that lipid abnormalities are not only
common in Nigerians newly presenting HTN, but it
also worsens with severity of HTN [31 32]. These
publications further recommended screening for lipid
abnormalities as an important investigation in the
evaluation of Nigerians presenting with HTN [31,32].
It is well known that institution of therapy for dyslip-
idemia when detected is desirable to reduce the ad-
verse multiplicative effects of coexisting HTN and
lipid abnormalities [33].
Tobacco causes an estimated 10% of CVD and is the
second leading cause of CVD after HTN with both its
chewing and smoking causing CVD [34]. Majority of the
respondents inquired about tobacco use showing thatthey understood its implications as a comorbid factor in
HTN management.
The presence of cardiac damage in two thirds of the
newly diagnosed hypertensive Nigerians makes electro-
cardiography (ECG) imperative in their management
[16]. ECG was routinely carried out by only half (51.3%)
of the GPs in this study. This is comparable to 42.7% re-
ported for GPs in Cameroon which is also a sub-Saharan
African country, but far lower than 94.8% reported for
GPs in India [21,29]. Ignorance of the magnitude of
hypertensive heart disease among Nigerians by this cohort
may underlie this practice, since facilities for electrocardiog-
raphy are readily and widely available in Lagos. Affordabil-
ity to Nigerian patients of this evaluation tool may also be a
reason for both its low utilization by GPs in our study and
the disparity observed between Nigerian and Indian GPs in
the usage of electrocardiography.
Retinopathy has been reported to occur in 71% of
Nigerians newly diagnosed with HTN [16]. However,
examination of the optic fundi was rarely (5.25%) done
by GPs in our study. This is lower than 10.4% reported
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utilization of fundoscopy by the GPs in these studies
may be due to limited expertise and/or time constraints.
The importance of fundoscopy in the management and
prognostication of hypertensive patients may also not be
adequately appreciated by these physicians.
This study has some limitations. First, the use of self-
administered questionnaire is influenced by recall and
the tendency to state the ideal rather than the actual
practice; hence, a study based on medical database
would have been ideal. In addition, though the participa-
tion was voluntary, the use of a cohort of GPs attending
continuing medical education program may not rule out
selection bias. In spite of these limitations, this study
provides a benchmark for further studies in this area.
Conclusion
Compliance to guidelines on various aspects of the de-
tection and evaluation of hypertension by this cohort
though heterogeneous is unsatisfactory. This engenders
the need for continuous education on hypertension for
GPs in Lagos in order to be kept abreast with current
management strategies on hypertension.
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